| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Rovaldi Christopher | Chief Operating Officer | Apr 06, 2022 | Option Exercise | $40.50 | 3,456 | 139,968 | 1,728 | Apr 08, 2022, 04:21 PM | |
| KROS | Keros Therapeutics, Inc. | Rovaldi Christopher | Chief Operating Officer | Apr 01, 2022 | Sale | $36.75 | 1,728 | 63,499 | 864 | Apr 05, 2022, 04:31 PM | |
| XLRN | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Apr 03, 2018 | Sale | $38.40 | 3,500 | 134,395 | 26,458 | Apr 04, 2018, 04:41 PM | |
| XLRN | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Jan 12, 2018 | Sale | $34.56 | 22,000 | 760,210 | 35,701 | Jan 17, 2018, 05:14 PM | |
| XLRN | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Jan 02, 2018 | Sale | $42.41 | 1,433 | 60,774 | 25,534 | Jan 04, 2018, 07:05 PM | |
| XLRN | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Jan 03, 2018 | Sale | $42.45 | 833 | 35,361 | 24,701 | Jan 04, 2018, 07:05 PM | |
| XLRN | ACCELERON PHARMA INC | Rovaldi Christopher | SVP, Program Mgmt and Ops | Sep 12, 2017 | Sale | $38.41 | 14,000 | 537,786 | 28,232 | Sep 14, 2017, 05:04 PM |
Menu